<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4867</id>
  <title>T3D4812</title>
  <common-name>Alpha-Linolenic Acid</common-name>
  <description>Alpha-linolenic acid (ALA) is a polyunsaturated omega-3 fatty acid. It is a component of many common vegetable oils and is important to human nutrition. </description>
  <cas>463-40-1</cas>
  <pubchem-id>5280934</pubchem-id>
  <chemical-formula>C18H30O2</chemical-formula>
  <weight>278.4</weight>
  <appearance></appearance>
  <melting-point>-16.5°C</melting-point>
  <boiling-point>231°C at 1.70E+01 mm Hg</boiling-point>
  <density nil="true"/>
  <solubility>0.000124 mg/mL at 25°C</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity>Alpha Linolenic Acid or ALA is considered an essential fatty acid because it is required for human health, but cannot be synthesized by humans. It is in fact  a plant-derived fatty acid. Humans can synthesize other omega-3 fatty acids from ALA, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-inflammatory and anti-atherogenic properties. ALA metabolites may also inhibit the production of the pro-inflammatory eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), as well as the pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta). Omega-3 fatty acids like ALA and its byproducts can modulate the expression of a number of genes, including those involved with fatty acid metabolism and inflammation. They regulate gene expression through their effects on the activity of transcription factors including NF-kappa B and members of the peroxisome proliferator-activated receptor (PPAR) family. Incorporation of ALA and its metabolites in cell membranes can affect membrane fluidity and may play a role in anti-inflammatory activity, inhibition of platelet aggregation and possibly in anti-proliferative actions of ALA. ALA is first metabolized by delta6 desaturease into steridonic acid.</mechanism-of-toxicity>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>Not listed by IARC.</carcinogenicity>
  <use-source>For nutritional supplementation and for treating dietary shortage or imbalance.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-09-11T05:17:40Z</created-at>
  <updated-at type="dateTime">2026-04-17T17:16:50Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Alpha-linolenic_acid</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C06427</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>27432</chebi-id>
  <biocyc-id>LINOLENIC_ACID</biocyc-id>
  <ctd-id>D017962</ctd-id>
  <stitch-id nil="true"/>
  <drugbank-id>DB00132</drugbank-id>
  <pdb-id>LNL</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O</moldb-smiles>
  <moldb-formula>C18H30O2</moldb-formula>
  <moldb-inchi>InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-</moldb-inchi>
  <moldb-inchikey>DTOSIQBPPRVQHS-PDBXOOCHSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">278.4296</moldb-average-mass>
  <moldb-mono-mass type="decimal">278.224580204</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Liquid</state>
  <logp>6.46</logp>
  <hmdb-id>HMDB01388</hmdb-id>
  <chembl-id>CHEMBL8739</chembl-id>
  <chemspider-id>4444437</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Jean-Pierre Masse, &amp;#8220;Therapeutic composition containing alpha-linolenic acid and a compound capable of promoting the passage of the acid through the cell membrane, plant extract comprising the acid and the compound, and process for the preparation of the extract.&amp;#8221; U.S. Patent US5002767, issued February, 1986.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003769</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid</iupac>
</compound>
